Target toxicity design for phase I dose-finding

DOI10.1080/24754269.2020.1800331OpenAlexW3049160390MaRDI QIDQ5880075

Wenchuan Guo, Bob Zhong

Publication date: 7 March 2023

Published in: Statistical Theory and Related Fields (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/24754269.2020.1800331

zbMATH Keywords

powerdose-findingphase IMTDgroup-sequential-like designsrecommended phase II doses

Mathematics Subject Classification ID

Statistics (62-XX)

Cites Work

• Unnamed Item
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Design efficiency in dose finding studies
• Operating characteristics of the standard phase I clinical trial design.
• Cumulative cohort design for dose-finding
• Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities

This page was built for publication: Target toxicity design for phase I dose-finding